4
Changes in Ownership
SANGAMO THERAPEUTICS, INC Filed Acc 0001415889-25-005708
Head of Research & Technology gave up 1,212 shares (to pay taxes)
- Head of Research & Technology acquired 49,726 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Davis Gregory D · Head of Research & Technology
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Shares withheld for taxes : show line 1 in the form | −705 | $1.00 | $705 | 166,865 | D |
| 2025-02-25 | Shares withheld for taxes : show line 2 in the form | −507 | $0.96 | $485 | 166,358 | D |
| 2025-02-25 | Grant or award : show line 3 in the form | +49,726 | 216,084 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-25 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +99,454 | 99,454 | D |
Loading xslF345X05/form4-02262025_100209.xml…